NDA 020238 · Medtech Products
Tagamet Hb
Cimetidine · Oral · Histamine-2 Receptor Antagonist
Last checked: Nov 21, 2026Latest source record: May 24, 2022 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1995
Jun 19, 1995
Approved uses
3
Original approval plus efficacy supplements
Registered trials
42
8 Phase 3, 2 recruiting
FAERS reports
9,313
7,592 serious, 1,182 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Jun 10, 2024.
Uses relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 5, 1998 Supplement 6 · Efficacy
- Nov 15, 1995 Supplement 4 · Efficacy
- Jun 19, 1995 Original approval · Type 8 - Partial Rx to OTC Switch
2 products under this application
- TAGAMET HB · CIMETIDINE 200MG · TABLET, ORAL · Over-the-counter
- TAGAMET HB · CIMETIDINE 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET, ORAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Cimetidine" as an intervention, any sponsor and status, largest first.
- Prophylaxis for Aspiration of Gastric Contents.Pivotal-lookingCompleted
King Saud UniversityAcademic, hospital or other
NCT02703896 · 1,920 participants · Start Jan 2012 · Primary completion Jan 2012
Drug: Drug either PPIS or H2RA and prokinetics · For: Pulmonary Aspiration of Gastric Contents
- Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerPivotal-lookingStatus unknown
Beijing Biostar Pharmaceuticals Co., Ltd.Industry
NCT05673590 · 612 participants (planned) · Start May 12, 2023 · Primary completion Jun 15, 2025
Drug: Utidelone Injection; Docetaxel Injection · For: Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sites: Shanghai, China
- Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically IllPivotal-lookingCompleted
Bausch Health Americas, Inc.Industry
NCT00045799 · 354 participants · Start May 2002
Drug: Omeprazole sodium bicarbonate immediate release PWD/FS; Cimetidine IV · For: Upper Gastrointestinal Bleeding
Sites: Birmingham, Alabama; Mobile, Alabama; Phoenix, Arizona · 58 sites in all
- Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill PatientsPivotal-lookingCompleted
AstraZenecaAstraZeneca (AZN)
NCT02157376 · 343 participants · Start Jul 2014 · Primary completion Feb 2016
Drug: Esomeprazole; Cimetidine · For: Stress Ulcer Prophylaxis
Sites: Baotou, China; Changsha, China; Chengdu, China · 15 sites in all
- High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic UlcerPivotal-lookingCompleted
AstraZenecaAstraZeneca (AZN)
NCT01757275 · 239 participants · Start Feb 2013 · Primary completion Dec 2014
Drug: Esomeprazole Na; Cimetidine and 1 more · For: Bleeding Peptic Ulcer
Sites: Beijing, China; Changsha, China; Chongqing, China · 12 sites in all
- Prulifloxacin in Chronic Bacterial Prostatitis (CBP)Pivotal-lookingCompleted
Aziende Chimiche Riunite Angelini Francesco S.p.AIndustry
NCT03201796 · 168 participants · Start Feb 2, 2016 · Primary completion May 19, 2020
Drug: Prulifloxacin 600 mg; Levofloxacin 500mg · For: Chronic Bacterial Prostatitis
Sites: Athens, Greece; Piraeus, Greece; Avellino, Italy · 11 sites in all
- Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelPivotal-lookingCompleted
Ohio State University Comprehensive Cancer CenterAcademic, hospital or other
NCT04862585 · 130 participants · Start Oct 7, 2021 · Primary completion Jun 21, 2024
Drug: Cimetidine; Dexamethasone and 4 more · For: Anatomic Stage 0 Breast Cancer AJCC v8; Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8 and 22 more
Sites: Columbus, Ohio
- Platelet Rich Plasma to Treat Plantar FasciitisPivotal-lookingCompleted
Zimmer BiometIndustry
NCT00758641 · 115 participants · Start Sep 2009 · Primary completion Jan 2016
Drug: Corticosteroid Injection · For: Plantar Fasciitis
Sites: DenHaag, Netherlands; Dordrecht, Netherlands; Leiden, Netherlands · 5 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- chronic kidney disease1,264
- acute kidney injury716
- nausea698
- renal failure694
- fatigue606
- drug ineffective510
- dyspnoea507
- vomiting493
- diarrhoea454
- pain439
- death403
- dizziness388
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 351 |
| 2005 | 479 |
| 2006 | 351 |
| 2007 | 186 |
| 2008 | 275 |
| 2009 | 279 |
| 2010 | 321 |
| 2011 | 368 |
| 2012 | 647 |
| 2013 | 288 |
| 2014 | 222 |
| 2015 | 349 |
| 2016 | 348 |
| 2017 | 350 |
| 2018 | 685 |
| 2019 | 1,032 |
| 2020 | 599 |
| 2021 | 590 |
| 2022 | 449 |
| 2023 | 377 |
| 2024 | 314 |
| 2025 | 265 |
| 2026 | 185 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux.
Larrain A, Carrasco E, Galleguillos F, et al. · Chest 1991 · Clinical Trial, Randomized Controlled Trial
- Lack of effect of cimetidine on the pharmacokinetics of bupivacaine in healthy subjects.
Pihlajamäki KK, Lindberg RL, Jantunen ME · Br J Clin Pharmacol 1988 · Clinical Trial, Randomized Controlled Trial
- Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.
Kelbaek H, Linde J, Eriksen J, et al. · Acta Med Scand 1985 · Clinical Trial, Randomized Controlled Trial
- Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.
Lee FI, Fielding JD, Costello FT · Postgrad Med J 1983 · Clinical Trial, Comparative Study
- Cimetidine preserves non-specific immune function after colonic resection for cancer.
Adams WJ, Morris DL, Ross WB, et al. · Aust N Z J Surg 1994 · Clinical Trial, Randomized Controlled Trial
- The effect of H1 and H2 histamine antagonists on symptomatic dermographism.
Matthews CN, Boss JM, Warin RP, et al. · Br J Dermatol 1979 · Clinical Trial, Randomized Controlled Trial
Sponsor: Medtech Products
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.